RITALIN CII

Indications for RITALIN:

Attention deficit hyperactivity disorder. Narcolepsy.

Adult Dose for RITALIN:

10–60mg daily in 2–3 divided doses preferably 30–45 minutes before meals.

Children's Dose for RITALIN:

<6yrs: not recommended. ≥6yrs: initially 5mg twice daily before breakfast and lunch. May increase by 5–10mg weekly; max 60mg/day.

See Also:

RITALIN LA

RITALIN-SR

Pharmacological Class:

Stimulant.

Contraindications:

Marked anxiety, tension, agitation. Glaucoma. History of tics or Tourette's syndrome in patient or family. During or within 14 days of MAOIs.

Warnings/Precautions:

Discontinue if seizures or agitation occur. Reduce dose or discontinue if paradoxical worsening of symptoms occurs. Reassess periodically. Reevaluate therapy at puberty. Hypertension. Psychosis. Seizure disorders. Depression. Normal fatigue states. Emotionally unstable (eg, drug or alcohol abusers). May exacerbate behavior disturbances, thought disorders. Monitor growth, BP, CBC, differential, platelet counts. Pregnancy (Cat.C). Nursing mothers.

Interactions:

See Contraindications. Caution with pressor agents, α₂-agonists (eg, clonidine). May increase levels of anticonvulsants, oral anticoagulants, tricyclics, phenylbutazone. Antagonizes guanethidine, other antihypertensives. Drugs that affect GI pH may affect release of methylphenidate from caps.

Adverse Reactions:

Insomnia, nervousness, CNS overstimulation, anorexia, weight loss, abdominal pain, nausea, dizziness, headache, dyskinesias, hypertension, tachycardia, arrhythmias, Tourette's syndrome, toxic psychosis, seizures, blood dyscrasias, rash, visual disturbances.

How Supplied:

caps, tabs—100